Exploring the Efficacy and Potential of Lutetium-177 Radioligand Therapy for Prostate Cancer ManagementProstate cancer is a prevalent and aggressive form of cancer, particularly in its metastatic castration-resistant state.Category: HEALTH CARECategory: ONCOLOGYCategory: PROSTATE CANCERCategory: LUTETIUMCategory: TREATMENT
Lutetium-177 PSMA Targeted Therapy for Prostate Cancer: Advances, Applications, and ProspectsThis review explores the emergence and application of Lutetium-177 (177Lu) PSMA radioligand therapy in prostate cancer management.Category: HEALTH CARECategory: ONCOLOGYCategory: PROSTATE CANCERCategory: LUTETIUM
